S. Subzwari

A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

C. Rudin, M. Kris, W. Travis, 2010, Cancer Chemotherapy and Pharmacology.

Pralatrexate with Vitamin Supplementation in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer: Safety and Efficacy in a Phase 1 Trial

M. Kris, C. Azzoli, M. Ginsberg, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.

C. Rudin, M. Kris, W. Travis, 2011, Lung cancer.

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA

K. Savage, H. Schoder, A. Dogan, 2023, Hematological Oncology.